Cochrane Abstracts
Fertility‐sparing treatment for atypical endometrial hyperplasia and endometrial cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Fertility‐sparing Treatment for Atypical Endometrial Hyperplasia and Endometrial Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440783/all/Fertility‐sparing_treatment_for_atypical_endometrial_hyperplasia_and_endometrial_cancer.
Fertility‐sparing treatment for atypical endometrial hyperplasia and endometrial cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440783/all/Fertility‐sparing_treatment_for_atypical_endometrial_hyperplasia_and_endometrial_cancer. Accessed January 16, 2026.
Fertility‐sparing treatment for atypical endometrial hyperplasia and endometrial cancer. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440783/all/Fertility‐sparing_treatment_for_atypical_endometrial_hyperplasia_and_endometrial_cancer
Fertility‐sparing Treatment for Atypical Endometrial Hyperplasia and Endometrial Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440783/all/Fertility‐sparing_treatment_for_atypical_endometrial_hyperplasia_and_endometrial_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Fertility‐sparing treatment for atypical endometrial hyperplasia and endometrial cancer
ID - 440783
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440783/all/Fertility‐sparing_treatment_for_atypical_endometrial_hyperplasia_and_endometrial_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
